Ellen Hoffing

Ellen Hoffing has more than 30 years of pharmaceutical, diagnostics, and healthcare consumer products industry experience in general management, portfolio and strategic planning, marketing and finance. Most recently, she served on the board of directors of Perrigo Co. Plc and provided consulting services in the public and private healthcare sectors.

Ellen served as the COO at Neos Therapeutics, and as Chairman and CEO of a diagnostic and early-stage drug development company in the Alzheimer’s space. She started her career at Searle and served on the management team. Ellen also held executive management roles at Baxter, American Pharmaceutical Partners Inc. and Merisant.

She received her bachelor’s degree in accounting from the University of Illinois, and her master’s degree in business administration from Northwestern’s Kellogg School of Management.